Login to Your Account



Merck Delays Cetuximab Filing To Add Colorectal Trial Data

By Randall Osborne


Thursday, April 25, 2002
Saying it wants a more robust data package for the FDA-stalled cancer drug cetuximab, Merck KGaA is delaying until the first half of next year the European regulatory filing, but now aims to include colorectal data as well as the originally planned head and neck cancer study results. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription